Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients

INTRODUCTION: Tumour burden is a prognostic biomarker in metastatic melanoma. However, tumour burden is difficult to measure and there are currently no reliable surrogate biomarkers to easily and reliably determine it. The aim of this study was to assess the potential of plasma total cell free DNA a...

Descripción completa

Detalles Bibliográficos
Autores principales: Valpione, S., Gremel, G., Mundra, P., Middlehurst, P., Galvani, E., Girotti, M.R., Lee, R.J., Garner, G., Dhomen, N., Lorigan, P.C., Marais, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Ltd 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769519/
https://www.ncbi.nlm.nih.gov/pubmed/29175734
http://dx.doi.org/10.1016/j.ejca.2017.10.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769519/
https://www.ncbi.nlm.nih.gov/pubmed/29175734
http://dx.doi.org/10.1016/j.ejca.2017.10.029

Ejemplares similares